However, subgroup analysis based on insulin levels in type 2 diabetes mellitus showed, patients with insulin levels beyond >20 μIU/ml had a higher MACE rate 42.4% (38) compared to those with insulin levels <20 μIU/ml [10.2% (12)] (p < 0.001). The gene discussed is INS; the disease is diabetes mellitus.